Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

BroadenBio Co., Ltd. is a clinical-stage biotechnology company focused on oncology and autoimmune diseases. Co-founded by senior drug discovery and development experts returning from global pharmaceutical companies, the organization has built proprietary immunology and molecular conjugation platforms. Guided by an “Immuno-Oncology 2.0” strategy integrating immunotherapy and targeted approaches, BroadenBio advances first- a...
BroadenBio Co., Ltd. is a clinical-stage biotechnology company focused on oncology and autoimmune diseases. Co-founded by senior drug discovery and development experts returning from global pharmaceutical companies, the organization has built proprietary immunology and molecular conjugation platforms. Guided by an “Immuno-Oncology 2.0” strategy integrating immunotherapy and targeted approaches, BroadenBio advances first- and best-in-class pipelines to address unmet clinical needs while pursuing domestic and international collaborations to improve human health.

List your booth number for exhibitions, ask us